Usual care dietary practice, achievement and implications for medication in the management of hypercholesterolaemia

European Heart Journal

Volumn 19, Issue 9, 1998, Pages 1328-1333

  Butowski, P F ^a   Winder, A F ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Body weight; Clinical protocols; Diet; Evidence based medicine; Hypercholesterolaemia

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; STATIN;

ADULT; ARTICLE; BODY WEIGHT; DATA BASE; DIET THERAPY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUESTIONNAIRE; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; AGED; AMBULATORY CARE; ANTICHOLESTEREMIC AGENTS; DIET, FAT-RESTRICTED; FEMALE; GREAT BRITAIN; HUMANS; HYPERCHOLESTEROLEMIA; LIPIDS; MALE; MIDDLE AGED; QUESTIONNAIRES; REGISTRIES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 0032170894     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1998.1044     Document Type: Article

References (30)

1. [1] Betteridge DJ, Dodson PM, Hughes EA et al. Management of hyperlipidaemia - guidelines of the British Hyperlipidaemia Association. Postgrad Med J 1993; 69: 359-69
2. [2] The Expert Panel. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 1993; 269: 3015-23.
3. [3] Pyorala K, De Backer G, Poole-Wilson P, Wood D. Prevention of heart disease in clinical practice. Recommendations of the task force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994; 15: 1300-31.
4. [4] Ramsay LE, Yeo WW, Jackson PR. Dietary reduction of serum cholesterol concentration: time to think again. BMJ 1991; 303: 953-7.
5. [5] Corr LA, Oliver MF. The low fat/low cholesterol diet is ineffective. Eur Heart J 1997; 18: 18-22.
6. [6] Hegsted DM, Ausman LM, Johnson JA, Dallal GE. Dietary fat and serum lipids: an evaluation of the evidence. Am J Clin Nutr 1993; 57: 875-83.
7. [7] Denke MA. Diet and lifestyle modification and its relationship to atherosclerosis. Medical Clinics of North America 1994; 78: 197-223.
8. [8] Denke MA. Cholesterol-lowering diets. A review of the evidence. Arch Intern Med 1995; 155: 17-26.
9. [9] Silagy C, Muir J, Coulter A, Thorogood M, Yudkin P, Roe L. Cardiovascular risk and attitudes to lifestyle: what do patients think? BMJ 1993; 307: 380-1.
10. [10] Frantz ID, Dawson EA, Ashman PL et al. Test of effect of lipid lowering by diet on cardiovascular risk. The Minnesota coronary survey. Arterosclerosis 1989; 9: 129-35.
11. [11] Ornish DM, Brown SE, Scherwitz LW et al. Can lifestyle changes reverse coronary heart disease? Lancet 1990; 32: 129-33.
12. [12] Cobb M, Teitelbaum HS, Breslow JL. Lovastatin efficacy in reducing low-density lipoprotein cholesterol levels on high-vs low-fat diets. JAMA 1991; 265: 997-1001.
13. [13] Hunningkake DB, Stein EA, Dujovne CA et al. The efficacy of intensive dietary therapy alone or combined with lovastatin in patients with hypercholesterolemia. N Engl J Med 1993; 328: 1213-9.
14. [14] Ascherio A, Rimm EB, Giovannucci EL, Spiegelman D, Stampfer M, Willett WC. Dietary fat and risk of coronary heart disease in men: cohort follow-up in the United States. Br Med J 1996; 313: 84-90.
15. [15] Van Horn L. Fiber, lipids and coronary heart disease. A statement for healthcare professionals from the nutrition committee, American Heart Association. Circulation 1997; 95: 2701-4.
16. [16] Mann JI, Appleby PN, Key TJ, Thorogood M. Dietary determinants of ischaemic heart disease in health conscious individuals. Heart 1997; 78: 150-5.
17. [17] Rifai N, Warnick GR, eds. Laboratory measurement of lipids, lipoproteins and apolipoproteins. AACC Press, Washington DC, 1994, pp. 1-357.
18. [18] Winder AF, Vallance DT, Richmond W. Investigation of dyslipidaemias. ACP Broadsheet No 151. J Clin Path 1997; 50: 721-34.
19. [19] Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein in plasma without use of the ultracentrifuge. Clin Chem 1972; 18: 499-502.
20. [20] Denke MA, Frantz Jr ID. Response to a cholesterol-lowering diet: efficacy is greater in hypercholesterolemic subjects even after adjustment for regression to the mean. Am J Med 1993; 94: 626-31.
21. [21] Law MR, WaId NJ. Wu T, Hackshaw A, Bailey A. Systematic underestimation of association between serum cholesterol and ischaemic heart disease in observational studies: data from the BUPA study. BMJ 1994; 308: 363-6.
22. [22] Scandinavian Simvastatin Survival group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study 4S. Lancet 1994; 344: 1383-9.
23. [23] Shepherd J, Cobbe SM, Ford I et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia. N Engl J Med 1995; 333: 1301-7.
24. [24] Sacks FM, Pfeffer MA, Moye LA et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1001-9.
25. [25] Schaefer EJ, Lichtenstein AH, Lamon-Fava S et al. Efficacy of a National Cholesterol Education Program step 2 diet in normolipidemic and hypercholesterolemic middle-aged and elderly men and women. Arterioscler Thromb Vasc Biol 1995; 15: 1079-85.
26. [26] Denke MA, Grundy SM. Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia. Arch Intern Med 1995; 155: 393-9.
27. [27] Wood PD, Stefanick ML, Williams PT, Haskell WL. The effects on plasma lipoproteins of a prudent weight-reducing diet with or without exercise in overweight men or women. N Engl J Med 1991; 325: 461-6.
28. [28] Katzel LI, Bleeker ER, Colman EG, Rogus EM, Sorkin JD, Goldberg AP. Effects of weight loss vs aerobic exercise training on risk factors for coronary disease in healthy, obese, middle-aged and older men. A randomised controlled trial. JAMA 1995; 274: 1915-21.
29. [29] Grimm RH, Flack JM, Grandits JA et al. Long-term effects on plasma lipids of diet and drugs to treat hypertension. JAMA 1996; 275: 1549-56.
30. [30] Aspire Steering Group. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events). Principal results. Heart 1996; 75: 334-42.